DarioHealth Corp.
DRIO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001533998
In the last 90 days, DarioHealth Corp. insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $9.69M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $100.0K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 21
- 13F valueReported value at the end of Q2 2026
- $9.69M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DRIO, Q2 2026
No superinvestor reported holding DRIO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by DarioHealth Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 (view filing)5:27 PM ET | Jul 23 | 5 daysLate | Matheis DennisDirector | PPurchase | +14.4K | $6.93 | +$100.0K | +50.5%43.0K after | |
| Aug 27, 2025 (view filing) | Aug 27 | Same day | Nelson Steven CharlesPresident and CCO | PPurchase | +40.0K | $0.53 | +$21.2K | +72.7%95.0K after | |
| Jan 10, 2025 (view filing) | Jan 7 | 3 days | Stern Adam KDirector | PPurchaseSeries D-2 Preferred Stock | +100 | $1,000.00 | +$100.0K | –0 after | Derivative |
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | Nelson Steven CharlesChief Commercial Officer | PPurchase | +5.00K | $0.91 | +$4.55K | +10.0%55.0K after | |
| Sep 12, 2024 (view filing) | Sep 10-11 | 2 days | Nelson Steven CharlesChief Commercial Officer | PPurchase | +10.0K | $0.82 | +$8.20K | +25.0%50.0K after | 2 lots |
| Sep 10, 2024 (view filing) | Sep 5-9 | 5 daysLate | Nelson Steven CharlesChief Commercial Officer | PPurchase | +15.0K | $0.82 | +$12.3K | +60.0%40.0K after | 3 lots |
| Aug 28, 2024 (view filing) | Aug 27 | 1 day | Raphael ErezChief Executive Officer | PPurchase | +5.00K | $0.88 | +$4.40K | +0.3%1.94M after | |
| Aug 23, 2024 (view filing) | Aug 21-23 | 2 days | Nelson Steven CharlesChief Commercial Officer | PPurchase | +15.0K | $0.9433 | +$14.2K | +150.0%25.0K after | 3 lots |
| Aug 23, 2024 (view filing) | Aug 20-21 | 3 daysLate | Raphael ErezChief Executive Officer | PPurchase | +10.0K | $0.94 | +$9.40K | +0.5%1.93M after | 2 lots |
| Aug 20, 2024 (view filing) | Aug 19-20 | 1 day | Nelson Steven CharlesChief Commercial Officer | PPurchase | +10.0K | $0.93 | +$9.30K | New position10.0K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in DarioHealth Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 1,221,382 | $8.06M | 0.24% | +610,692+100.0% | Added |
| Vanguard Capital Management LLC | 65,675 | $433.5K | 0.00% | −235−0.4% | Reduced |
| Geode Capital Management, LLC | 58,035 | $383.3K | 0.00% | −3,843−6.2% | Reduced |
| BlackRock, Inc. | 37,796 | $249.5K | 0.00% | +18,978+100.9% | Added |
| Vanguard Fiduciary Trust Co | 37,387 | $246.8K | 0.00% | +7,317+24.3% | Added |
| Citadel Advisors LLC | 24,289 | $160.3K | 0.00% | +3,829+18.7% | Added |
| Northern Trust Corp | 13,237 | $87.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 3,321 | $21.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,000 | $19.8K | 0.00% | +2,000+200.0% | Added |
| Advisor Group Holdings, Inc. | 1,900 | $12.5K | 0.00% | +1,899+189,900.0% | Added |